Last reviewed · How we verify

GEPIRONE — Competitive Intelligence Brief

GEPIRONE (GEPIRONE) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: gepirone. Area: Neuroscience.

marketed gepirone 5HT1A receptors Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

GEPIRONE (GEPIRONE). EXXUA's antidepressant effect may stem from modulating serotonergic activity via selective agonist activity at 5HT1A receptors.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
GEPIRONE TARGET GEPIRONE marketed gepirone 5HT1A receptors 2023-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (gepirone class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). GEPIRONE — Competitive Intelligence Brief. https://druglandscape.com/ci/gepirone. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: